1. Home
  2. A combination efficacy study in Africa of two DNA-MVA- or DNA- Env protein HIV-1 vaccine regimens with pre-exposure prophylaxis (PrEP)
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY

A combination efficacy study in Africa of two DNA-MVA- or DNA- Env protein HIV-1 vaccine regimens with pre-exposure prophylaxis (PrEP)

IATI Identifier: GB-GOV-13-OODA-MRC-MK6NR8M-EPCELQG-BTZDKEX

Transactions

Incoming Funds

Funds that originate from a source other than the donor(s) reported in the activity.
Calculating.. Funds received from an external funding source.

Download data

CSV

Commitments

A firm obligation to provide resources of a specified amount.
Calculating..

Download data

CSV

Disbursements

The amount placed at the disposal of a recipient country or agency.
Calculating..

Download data

CSV

Expenditure

Funds spent on goods and services.
Calculating..

Download data

CSV

Interest Repayment

Amount of interest paid on a loan or line of credit, including fees
Calculating..

Download data

CSV

Loan Repayment

The actual amount of principal (amortisation) repaid, including any arrears
Calculating..

Download data

CSV

Purchase of Equity

Outgoing funds to purchase equity
Calculating..

Download data

CSV